Ignite Creation Date:
2024-05-06 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 1:53 PM
Study NCT ID:
NCT04692155
Status:
TERMINATED
Last Update Posted:
2023-09-28
First Post:
2020-12-28
Brief Title:
Clinical Trial of Ublituximab and Umbralisib With CHOP U2-CHOP Followed by U2 Maintenance U2-CHOP-U2 in Previously Untreated Mantle Cell Lymphoma MCL
Sponsor:
University of Alabama at Birmingham
Organization:
University of Alabama at Birmingham
Organization Data
Organization:
University of Alabama at Birmingham
Class:
OTHER
Study ID:
IRB-300006404
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Alabama at Birmingham
Lead Sponsor Class:
OTHER
Responsible Party:
Amitkumar Mehta MD
Responsible Party Title:
Associate Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Alabama at Birmingham
Old Name:
None
Old Organization:
None